How the Infant Formula Recall Will Impact Abbott's Revenue

Baby formula is in short supply around the US, raising concerns about nutrition for the 3 out of 4 infants that rely on it for some portion of their nourishment. Supply chain issues have created problems since the start of the pandemic, but healthcare equipment provider Abbott Laboratories' (NYSE: ABT) division Abbott Nutrition in particular has drawn the heat for the current severe shortage. Despite Abbott's mounting losses, the company's recovery is in sight.